Hudson Bay Capital Management
RNAM

Hudson Bay Capital Management’s Avidity Biosciences RNAM Stock Holding History

Hudson Bay Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-218,226
Closed -$15.7M – 1565
2025
Q4 		$15.7M Buy
218,226
+188,226
+627% +$12.2M 0.05% 259
2025
Q3 		$1.31M Sell
30,000
-45,000
-60% -$1.82M ﹤0.01% 819
2025
Q2 		$2.13M Buy
+75,000
New +$2.24M 0.01% 779
2024
Q4 		– Sell
-30,000
Closed -$1.38M – 1084
2024
Q3 		$1.38M Buy
+30,000
New +$1.3M 0.01% 611

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Hudson Bay Capital Management's RNAM Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 218,226 shares — an estimated $15.7M sold.

Hudson Bay Capital Management first reported a position in RNAM in Q3 2024 and held it in 4 quarters. The position peaked at $15.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Hudson Bay Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 218,226 Avidity Biosciences shares in Q1 2026, an estimated $15.7M.
  • Hudson Bay Capital Management first reported a position in Avidity Biosciences in Q3 2024 and held it in 4 quarters.
  • Hudson Bay Capital Management's Avidity Biosciences position peaked at $15.7M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.